Weekly News Round-up – 28/2/20
Covid-19 continues to dominate the news, with pharma companies racing to find the cure. Moderna and Gilead look currently set to lead, with vaccines from both now entering human trials. In other news, Novartis' Beovu, which appeared in last week's...
5 years agoWeekly News Round-up – 28/2/20
Covid-19 continues to dominate the news, with pharma companies racing to find the cure. Moderna and Gilead look currently set to lead, with vaccines from both now entering human trials. In other news, Novartis' Beovu, which appeared in last week's...
5 years ago
Weekly News Round-up – 21/2/20
Fascinating news this week as scientists at MIT found the first strong antibiotics devised entirely by machine learning algorithm. The resulting medicines have so far proven highly effective against ‘critical’ pathogens. The scientists are now intending to search for more...
5 years agoWeekly News Round-up – 21/2/20
Fascinating news this week as scientists at MIT found the first strong antibiotics devised entirely by machine learning algorithm. The resulting medicines have so far proven highly effective against ‘critical’ pathogens. The scientists are now intending to search for more...
5 years ago
Weekly News Round-up – 14/2/20
The U.S. Institute for Clinical and Economic Review’s (ICER’s) methods could see legal challenges in the near future, a think tank has warned, due to discrimination against disabled individuals. In other news, Novartis’ rare lung cancer drug capmatinib will be...
5 years agoWeekly News Round-up – 14/2/20
The U.S. Institute for Clinical and Economic Review’s (ICER’s) methods could see legal challenges in the near future, a think tank has warned, due to discrimination against disabled individuals. In other news, Novartis’ rare lung cancer drug capmatinib will be...
5 years ago
Weekly News Round-up – 7/2/20
Two big pharma restructures this week,with both GSK and Merck making promises to spin off or divide their existing assets. GSK disappointed some investors with its £2.4 billion plan to separate its consumer health arm and save £700 million a...
5 years agoWeekly News Round-up – 7/2/20
Two big pharma restructures this week,with both GSK and Merck making promises to spin off or divide their existing assets. GSK disappointed some investors with its £2.4 billion plan to separate its consumer health arm and save £700 million a...
5 years ago
Weekly News Round-up – 31/1/20
With the Chinese Coronavirus dominating the news this week, headlines were a diverse affair: Novartis has backed out of a generic program copying Advair, with the company citing that they could no longer see a way to launch in the...
5 years agoWeekly News Round-up – 31/1/20
With the Chinese Coronavirus dominating the news this week, headlines were a diverse affair: Novartis has backed out of a generic program copying Advair, with the company citing that they could no longer see a way to launch in the...
5 years ago
Weekly News Round-up – 24/1/20
The World Health Organisation (WHO) has been in the news a lot this week, a fact that doesn't often herald good news. The first, of course, was to discuss the outbreak of a new coronavirus in China, against which no antidote...
5 years agoWeekly News Round-up – 24/1/20
The World Health Organisation (WHO) has been in the news a lot this week, a fact that doesn't often herald good news. The first, of course, was to discuss the outbreak of a new coronavirus in China, against which no antidote...
5 years ago
Weekly News Round-up – 17/1/20
The week passed fairly uneventfully this time, with the baffling politics and shocking events of the new decade struggling to get started. Instead, research from Scottish universities indicated a link between a type of common gut bacteria and Parkinson's; a...
5 years agoWeekly News Round-up – 17/1/20
The week passed fairly uneventfully this time, with the baffling politics and shocking events of the new decade struggling to get started. Instead, research from Scottish universities indicated a link between a type of common gut bacteria and Parkinson's; a...
5 years ago
Proventa’s Weekly Round-up – 10/1/19
Happy new year! It’s a fairly slow week as the sector takes stock and begins to get back, with annual price rises the main event in the news - big pharma has announced its regular price increases for the new...
5 years agoProventa’s Weekly Round-up – 10/1/19
Happy new year! It’s a fairly slow week as the sector takes stock and begins to get back, with annual price rises the main event in the news - big pharma has announced its regular price increases for the new...
5 years ago
Proventa’s Weekly Round-up – 20/12/19
Merry Christmas! This week in our segment on “the same three stories every week that are of broad general interest”, Trump’s administration has made an attempt to reduce U.S. drug prices with a plan to allow Canadian imports; Nancy Pelosi’s...
5 years agoProventa’s Weekly Round-up – 20/12/19
Merry Christmas! This week in our segment on “the same three stories every week that are of broad general interest”, Trump’s administration has made an attempt to reduce U.S. drug prices with a plan to allow Canadian imports; Nancy Pelosi’s...
5 years ago
Proventa’s Weekly Round-up – 13/12/19
Avoiding yesterday’s election and all it means for the UK and Brexit, much of the news this week happened across the pond: Pharma companies have reacted violently to the Republicans’ alleged reneging of drug patent rules in international negotiations, while...
5 years agoProventa’s Weekly Round-up – 13/12/19
Avoiding yesterday’s election and all it means for the UK and Brexit, much of the news this week happened across the pond: Pharma companies have reacted violently to the Republicans’ alleged reneging of drug patent rules in international negotiations, while...
5 years ago